Pfizer, Flagship Pioneering to Partner on Development of 10 Single-Asset Programs
$100 million investment to address pharma’s strategic areas of interest.
Pfizer and Flagship Pioneering, a life sciences venture capital organization, revealed in a press release their intentions to collaborate in an effort to create a new supply of innovative medicines. Per the agreement, both companies will invest $50 million towards developing 10 single-asset programs by leveraging Flagship’s ecosystem of human health companies and biotechnology platforms.
“At Pfizer, we are expanding our efforts to pursue potential breakthrough science with unique approaches and funding mechanisms designed to leverage the dynamic scientific ecosystem,” said Mikael Dolsten, MD, PhD, chief scientific officer, president, worldwide research, development and medical, Pfizer, in a company release.“This collaboration is an exciting opportunity for Pfizer to bring deep scientific expertise and apply our development and regulatory strength to Flagship’s diverse portfolio of technology platforms, translating early-stage innovation to potential medicines.”
Reference: Flagship Pioneering and Pfizer Partner to Accelerate Development of Innovative Medicines Targeting Unmet Needs. Pfizer. July 18, 2023. Accessed July 20, 2023. https://www.pfizer.com/news/press-release/press-release-detail/flagship-pioneering-and-pfizer-partner-accelerate
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
